Date | Title | Description | |
---|---|---|---|
25 Apr 2023 | On business and financial situation | ROVI commences clinical development of a new three-monthly formulation of Letrozole (Letrozole LEBE) | Download |
21 Feb 2023 | About Corporate Governance | The Company informs about the agreements adopted by the Board of Directors | Download |
21 Feb 2023 | On business and financial situation | The Company releases the full year 2022 financial results presentation. | Download |
21 Feb 2023 | On business and financial situation | The Company releases the press release related to the full year 2022 financial results. | Download |
21 Feb 2023 | On business and financial situation | The company releases the Integrated Report for the year 2022 | Download |
Pages
Date | Title | Description | |
---|---|---|---|
26 Feb 2020 | About corporate governance | The Company informs about the agreements adopted by the Board of Directors | Download |
26 Feb 2020 | Annual Corporate Governance Report | ROVI releases the 2019 Annual Corporate Governance Report | Download |
26 Feb 2020 | Annual Report regarding remuneration of the members of the Board of Directors | ROVI releases the 2019 annual report regarding remuneration of the members of the Board of Directors | Download |
Pages
Date | Title | Description | |
---|---|---|---|
08 May 2019 | Information on P&L | ROVI releases the first quarter 2019 results presentation | Download |
08 May 2019 | Information on P&L | ROVI releases the press release related to the first quarter 2019 financial results | Download |
07 May 2019 | Liquidity contracts and specialists | ROVI announces the signature of a new liquidity contract with Renta 4 Banco, S.A. | Download |
30 Apr 2019 | Liquidity contracts and specialists | ROVI announces the termination of the liquidity contract signed with JB Capital Markets, S.V., S.A.U. | Download |
11 Apr 2019 | Strategic agreements with third parties | The Company releases the press release related to the marketing agreement of Tetridar® in Spain | Download |